JP2021506907A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021506907A5 JP2021506907A5 JP2020534340A JP2020534340A JP2021506907A5 JP 2021506907 A5 JP2021506907 A5 JP 2021506907A5 JP 2020534340 A JP2020534340 A JP 2020534340A JP 2020534340 A JP2020534340 A JP 2020534340A JP 2021506907 A5 JP2021506907 A5 JP 2021506907A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- composition according
- renal dysfunction
- pema
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- ZHKNLJLMDFQVHJ-RUZDIDTESA-N (2r)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid Chemical compound CC[C@H](C(O)=O)OC1=CC=CC(CN(CCCOC=2C=CC(OC)=CC=2)C=2OC3=CC=CC=C3N=2)=C1 ZHKNLJLMDFQVHJ-RUZDIDTESA-N 0.000 claims 5
- 229950009401 pemafibrate Drugs 0.000 claims 5
- 230000008085 renal dysfunction Effects 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 3
- 108010023302 HDL Cholesterol Proteins 0.000 claims 2
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 2
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 1
- 108010028554 LDL Cholesterol Proteins 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 206010062237 Renal impairment Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023187862A JP2023181451A (ja) | 2017-12-21 | 2023-11-01 | 高トリグリセライド血症の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762609048P | 2017-12-21 | 2017-12-21 | |
| US62/609,048 | 2017-12-21 | ||
| PCT/US2018/066976 WO2019126597A1 (en) | 2017-12-21 | 2018-12-20 | Methods of treatment of hypertrigl yceridemia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023187862A Division JP2023181451A (ja) | 2017-12-21 | 2023-11-01 | 高トリグリセライド血症の治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021506907A JP2021506907A (ja) | 2021-02-22 |
| JP2021506907A5 true JP2021506907A5 (https=) | 2022-01-11 |
Family
ID=66995099
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020534340A Pending JP2021506907A (ja) | 2017-12-21 | 2018-12-20 | 高トリグリセライド血症の治療方法 |
| JP2023187862A Pending JP2023181451A (ja) | 2017-12-21 | 2023-11-01 | 高トリグリセライド血症の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023187862A Pending JP2023181451A (ja) | 2017-12-21 | 2023-11-01 | 高トリグリセライド血症の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20190224169A1 (https=) |
| EP (1) | EP3727376A4 (https=) |
| JP (2) | JP2021506907A (https=) |
| CN (1) | CN111741753A (https=) |
| AU (1) | AU2018393119B2 (https=) |
| CA (1) | CA3085951C (https=) |
| MY (1) | MY205171A (https=) |
| SG (1) | SG11202005850VA (https=) |
| WO (1) | WO2019126597A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250034041A (ko) * | 2022-07-15 | 2025-03-10 | 교와 가부시키가이샤 | 혈중 ldl 콜레스테롤 저하제 |
| WO2024167964A1 (en) * | 2023-02-08 | 2024-08-15 | Kowa Company, Ltd. | Methods of treating and preventing peripheral artery disease |
| WO2025069226A1 (ja) * | 2023-09-26 | 2025-04-03 | 興和株式会社 | ペマフィブラートを含有する医薬 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA009374B1 (ru) * | 2003-09-03 | 2007-12-28 | Кова Ко., Лтд. | Активирующее ppar соединение и содержащая его фармацевтическая композиция |
| TWI407955B (zh) | 2007-03-29 | 2013-09-11 | Kowa Co | 高脂血症之預防及／或治療劑 |
| KR102098032B1 (ko) * | 2012-09-27 | 2020-04-07 | 교와 가부시키가이샤 | 지질 이상증 치료제 |
| EP3160458A1 (en) * | 2014-06-26 | 2017-05-03 | Cymabay Therapeutics, Inc. | Treatment of severe hypertriglyceridemia |
| TWI691331B (zh) * | 2014-09-26 | 2020-04-21 | 日商興和股份有限公司 | 脂質異常症治療劑 |
| SI3275438T1 (sl) * | 2016-07-29 | 2021-05-31 | Kowa Company, Ltd. | Metode preprečevanja kardiovaskularnih dogodkov pri dislipidemični populaciji z rezidualnim tveganjem |
-
2018
- 2018-12-20 US US16/227,440 patent/US20190224169A1/en not_active Abandoned
- 2018-12-20 CA CA3085951A patent/CA3085951C/en active Active
- 2018-12-20 WO PCT/US2018/066976 patent/WO2019126597A1/en not_active Ceased
- 2018-12-20 SG SG11202005850VA patent/SG11202005850VA/en unknown
- 2018-12-20 CN CN201880089648.7A patent/CN111741753A/zh active Pending
- 2018-12-20 AU AU2018393119A patent/AU2018393119B2/en active Active
- 2018-12-20 MY MYPI2020003113A patent/MY205171A/en unknown
- 2018-12-20 EP EP18892061.5A patent/EP3727376A4/en active Pending
- 2018-12-20 JP JP2020534340A patent/JP2021506907A/ja active Pending
-
2023
- 2023-11-01 JP JP2023187862A patent/JP2023181451A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100296954B1 (ko) | 신규의항알러지항염증조성물 | |
| EA200800881A1 (ru) | Лекарственная форма пирфенидона в виде капсул с фармацевтически приемлемыми эксципиентами | |
| JP2024540183A5 (https=) | ||
| CA2393437A1 (en) | Exo-s-mecamylamine formulation and use in treatment | |
| JP2018507243A5 (https=) | ||
| JP2021152008A5 (https=) | ||
| CA2802093A1 (en) | Combination therapy with lisdexamphetamine and extended release guanfacine | |
| JP2023550149A5 (https=) | ||
| JP2024507810A5 (https=) | ||
| JP2021506907A5 (https=) | ||
| JP2024516795A5 (https=) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2018516266A5 (https=) | ||
| WO2009123206A1 (ja) | 経口医薬組成物 | |
| AU2016353350A1 (en) | Formulation of L-ornithine phenylacetate | |
| JP6642892B2 (ja) | ジメチルアミノミケリオリドを含む肺線維化の治療薬 | |
| CN107106875A (zh) | 使用半胱胺组合物治疗亨廷顿氏病的方法 | |
| JP2023531930A5 (https=) | ||
| MX2022012693A (es) | Composicion que comprende metilfolato. | |
| JP6100510B2 (ja) | 抗感冒剤 | |
| CA2469702A1 (en) | Darifenacin for use in the treatment of urgency induced by overactive bladder | |
| US9084769B2 (en) | Compositions comprising non steroidal anti-inflammatory drugs and methods for use thereof | |
| JP2025522146A5 (https=) | ||
| RU2018118603A (ru) | Фармацевтические композиции диметилфумарата | |
| Marlin et al. | PHARMACOKINETICS AND TOLERABILITY OF A SINGLE ORAL 600‐mg DOSE OF DOXYCYCLINE |